Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.7K Sell
30,915
-1,268
-4% -$2.42K ﹤0.01% 3485
2025
Q4
$69.2K Buy
32,183
+19,349
+151% +$66.1K ﹤0.01% 3398
2025
Q3
$61.9K Buy
12,834
+2,309
+22% +$12.6K ﹤0.01% 3410
2025
Q2
$58.4K Buy
10,525
+9,894
+1,568% +$78.3K ﹤0.01% 3391
2025
Q1
$7.74K Buy
+631
New +$9.63K ﹤0.01% 3506
2021
Q4
Sell
-43
Closed -$3K 4310
2021
Q3
$3K Buy
43
+4
+10% +$423 ﹤0.01% 4349
2021
Q2
$7K Buy
39
+3
+8% +$525 ﹤0.01% 4485
2021
Q1
$7K Sell
36
-32
-47% -$6.46K ﹤0.01% 4454
2020
Q4
$14K Buy
68
+34
+100% +$6.31K ﹤0.01% 4276
2020
Q3
$7K Buy
+34
New +$8.19K ﹤0.01% 4219

Other funds holding GOCO

Deutsche Bank's GOCO Position: Q1 2026 in Review

Deutsche Bank reduced its GoHealth (GOCO) stake by 3.9% in Q1 2026, selling an estimated $2.42K and leaving 30,915 shares worth $46.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3485.

Deutsche Bank first reported a position in GOCO in Q3 2020 and has held it in 10 quarters since. The position peaked at $69.2K in Q4 2025. 67 funds tracked by Wall St. Rank hold GOCO as of Q1 2026.

  • Deutsche Bank held 30,915 shares of GoHealth worth $46.7K as of Q1 2026.
  • Deutsche Bank sold 1,268 GoHealth shares in Q1 2026, an estimated $2.42K.
  • GoHealth made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3485 holding.
  • Deutsche Bank first reported a position in GoHealth in Q3 2020 and has held it in 10 quarters since.
  • Deutsche Bank's GoHealth position peaked at $69.2K in Q4 2025.
  • 67 funds tracked by Wall St. Rank held GoHealth as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.